Pacira Total Revenue from 2010 to 2024
PCRX Stock | USD 29.69 0.63 2.08% |
Total Revenue | First Reported 2008-12-31 | Previous Quarter 181.2 M | Current Value 167.1 M | Quarterly Volatility 56.8 M |
Check Pacira Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.4 M, Interest Expense of 16.1 M or Selling General Administrative of 63.1 M, as well as many exotic indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0 or PTB Ratio of 1.7. Pacira financial statements analysis is a perfect complement when working with Pacira Pharmaceuticals Valuation or Volatility modules.
Pacira | Total Revenue |
Latest Pacira Pharmaceuticals' Total Revenue Growth Pattern
Below is the plot of the Total Revenue of Pacira Pharmaceuticals over the last few years. Total revenue comprises all receipts Pacira Pharmaceuticals generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Pacira Pharmaceuticals' Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacira Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Total Revenue | 10 Years Trend |
|
Total Revenue |
Timeline |
Pacira Total Revenue Regression Statistics
Arithmetic Mean | 329,007,260 | |
Geometric Mean | 198,559,667 | |
Coefficient Of Variation | 73.07 | |
Mean Deviation | 195,752,411 | |
Median | 286,630,000 | |
Standard Deviation | 240,405,362 | |
Sample Variance | 57794.7T | |
Range | 694.8M | |
R-Value | 0.99 | |
Mean Square Error | 1605T | |
R-Squared | 0.97 | |
Slope | 53,058,644 | |
Total Sum of Squares | 809126.3T |
Pacira Total Revenue History
About Pacira Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Pacira Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Pacira Pharmaceuticals investors use historical funamental indicators, such as Pacira Pharmaceuticals's Total Revenue, to determine how well the company is positioned to perform in the future. Although Pacira Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Pacira Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Pacira Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Pacira Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Pacira Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Total Revenue | 675 M | 708.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pacira Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacira Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacira Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacira Pharmaceuticals Stock:Check out the analysis of Pacira Pharmaceuticals Correlation against competitors. For more information on how to buy Pacira Stock please use our How to Invest in Pacira Pharmaceuticals guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Pacira Stock analysis
When running Pacira Pharmaceuticals' price analysis, check to measure Pacira Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira Pharmaceuticals is operating at the current time. Most of Pacira Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pacira Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pacira Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Pacira Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacira Pharmaceuticals. If investors know Pacira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacira Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.291 | Earnings Share 1.51 | Revenue Per Share 14.706 | Quarterly Revenue Growth 0.042 | Return On Assets 0.0376 |
The market value of Pacira Pharmaceuticals is measured differently than its book value, which is the value of Pacira that is recorded on the company's balance sheet. Investors also form their own opinion of Pacira Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pacira Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacira Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pacira Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacira Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacira Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacira Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.